Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Validation of Serum Cardiac Troponin I Reference Materials Using an Immunoprecipitation Method Coupled with Fluorescent Western Blot Analysis

Published

Author(s)

Hua-Jun He, Mark Lowenthal, Kenneth D. Cole, David M. Bunk, Lili Wang

Abstract

Cardiac troponin I (cTnI) is adopted as the gold standard cardiac biomarker following the universal definition of myocardial infarction (MI). Presently, the performance of commercial cTnI immunoassays varies significantly despite the recalibration using a troponin standard reference material, NIST SRM 2921. To standardize the cTnI immunoassays, a secondary reference material consisting of a panel of cTnI-positive human serum pools, is proposed by IFCC Working Group for Standardization of Troponin I (IFCC WG-TNI) for assay manufacturers to reference their assay calibrations and for improving intra-assay comparability and harmonization. The establishment of a reference measurement procedure for cTnI is required for the value assignment of the cTnI concentration of the proposed secondary reference material. We developed an immunoprecipitation method coupled with fluorescent western blot analysis, which is designed to reduce the interference from cTnI heterogeneity and cTn autoantibodies and determine the cTnI concentration. We used magnetic beads coupled with 6 different anti-cTnI monoclonal antibodies that bind specifically to different amino acid sequence regions of the cTnI molecule to immunoprecipitate the cTnI proteins from a cTnI positive serum pool sample followed by sensitive detection using a fluorescent western blot. The cTnI degradation in the positive pool sample was confirmed and a total concentration of cTnI was determined. Moreover, cTnI and cTn autoantibodies were found in the same pool sample by a slightly modified method. We demonstrated the utility of this method for supporting the development of the secondary cTnI-positive serum based reference material for the standardization of clinical cTnI immunoassays.
Citation
Clinical Chemistry
Volume
412
Issue
1-2

Keywords

troponin, serum-based reference material, immunoprecipitation, western blot, validation.

Citation

He, H. , Lowenthal, M. , Cole, K. , Bunk, D. and Wang, L. (2011), Validation of Serum Cardiac Troponin I Reference Materials Using an Immunoprecipitation Method Coupled with Fluorescent Western Blot Analysis, Clinical Chemistry, [online], https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=903994 (Accessed September 27, 2022)
Created January 13, 2011, Updated October 12, 2021